STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Stemtech Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $207.74K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0049 (−98.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Stemtech Corp saw revenue fall 38.6% to $2.40M over the twelve months to Jun 30, 2026. Free cash flow was -$328.76K.
Revenue
$2.40M
-38.6% vs. a year earlier
Operating income
-$2.42M
TTM Q2 2026
Free cash flow
-$328.76K
TTM Q2 2026
EPS, diluted
-$0.02
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $207.74K
- P/E ratio
- –
- Price to sales
- 0.09
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -158.25%
Fundamentals
- Revenue
- $2.40M
- Net income
- -$3.84M
- EPS, diluted
- -$0.02
- Free cash flow
- -$328.76K
- Book value per share
- -$0.00
- Diluted shares
- 2.08B
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$2.40M-38.6% YoY
Gross profit
$1.86M-37.5% YoY
Operating income
-$2.42M
Net income
-$3.84M
EPS, diluted
-$0.02
Free cash flow
-$328.76K
Reported periodTrailing twelve months